With the first therapeutic ... cancer vaccines, with more than ten such products — designed to confer active, specific immunotherapy directed against tumour-associated antigens — in Phase III ...

A vaccine for pancreatic cancer could serve as a promising new therapy. At Memorial Sloan ... Results from the phase 1 clinical trial, published in the journal Nature, revealed that the vaccine ...

These formulations and combinations are under evaluation for a wide range of vaccine candidates in clinical trials. Here we describe cancer vaccine candidates using MPL adjuvant in the most ...

Using a vaccine ... therapeutic effect.” Importantly for a smaller-scale biotech such as Vaccitech having partners in Cancer Research UK and Ludwig will allow it to leverage the clinical trial ...

New results from the phase 1 clinical trial, now published in the journal Nature, show that the therapeutic cancer vaccine activated tumor-specific immune cells that persisted in the body up to nearly ...

There are more than 400 ongoing trials and more than 200 in the works, according to Citeline data. Therapeutic cancer vaccines differ from more traditional vaccines such as the human ...

QS-21 is currently being evaluated as an adjuvant for many different vaccine candidates ... QS-21 is in clinical trials, of which several are in late-stage development by Antigenics' licensees ...